aspirin has been researched along with cyclic gmp in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (35.63) | 18.7374 |
1990's | 25 (28.74) | 18.2507 |
2000's | 24 (27.59) | 29.6817 |
2010's | 7 (8.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riding, GV | 1 |
Kaliner, M | 1 |
Kaliner, M; Platshon, LF | 1 |
Austen, KF; Goetzl, EJ; Pickett, WC | 1 |
Silver, MJ; Smith, JB | 1 |
Haslam, RJ | 1 |
Farris, RK; Morris, SM; Powell, DW; Tapper, EJ | 1 |
Yasunaga, K | 1 |
George, DT; Mapes, CA; Sobocinski, PZ | 1 |
Carr, DW; Gerrard, JM; Glass, DB; Goldberg, ND; Townsend, D; White, JG | 1 |
Dekanski, JB; Gottfried, S; Macdonald, A; Parke, DV; Sacra, P | 1 |
Austen, KF; Goetzl, EJ; Pickett, W; Schoepflin, GS | 1 |
Austen, KF; Goetzl, EJ; Schoepflin, GS | 1 |
Castania, A; Rothschild, AM | 1 |
Krzanowski, JJ; Polson, JB; Szentivanyi, A | 1 |
Waitzman, MB | 1 |
Chiang, TM | 1 |
Moncada, S; Palmer, RM; Radomski, MW | 1 |
Bruckdorfer, KR; Dunn, RC; Feher, MD; Miles, CM; Schachter, M; Sever, PS; Tranter, PR | 1 |
Armstrong, RA; Jones, RL; Wilson, NH | 1 |
Axelsson, KL; Bornfeldt, KE | 1 |
Manganiello, VC; Stoner, J; Vaughan, M | 1 |
Haslam, RJ; McClenaghan, MD | 1 |
Goetter, WE | 1 |
Best, LC; Bone, EA; Holland, TK; Hunt, NH; Jones, PB | 1 |
Davis, BB; Rapp, NS; Zenser, TV | 1 |
Kolb, JP; Rochette-Egly, C; Tovey, MG | 1 |
Salzman, EW; Steer, ML | 1 |
Cornelius, LM; Evatt, BL; Waitzman, MB | 1 |
Cagen, LM; Chiang, TM; Kang, AH | 1 |
Kazmi, GM; Littner, MR; Lott, FD | 1 |
DeCampli, WM; Obayashi, DY; Wanna, FS; Young, JN | 1 |
Gulati, A; Sharma, AC; Singh, G | 1 |
Folts, JD; Loscalzo, J; Rovin, JD; Stamler, JS | 1 |
Gear, AR; Polanowska-Grabowska, R | 1 |
Hsu, P; Leffler, CW; Parfenova, H | 1 |
Ashikaga, T; Hata, A; Kishi, Y; Makita, T; Numano, F; Watanabe, R | 1 |
Freas, W; Hart, J; Jing, M; Llave, R; McQuillan, P; Muldoon, S | 1 |
Abendschein, DR; Meng, YY; Ryan, US; Trachtenburg, J | 1 |
Guandalini, S; Iafusco, M; Nocerino, A | 1 |
Alberola, ML; Caramelo, C; Casado, S; Esteban, A; López-Farré, A; Millás, I; Montón, M | 1 |
Grünberg, B; Kratzer, MA; Lorenz, R; Negrescu, EV; Siess, W | 1 |
Alexandre, A; Borean, A; Cavallini, L; Coassin, M | 1 |
Albert, J; Bröijersén, A; Frostell, C; Hjemdahl, P; Wallén, NH | 1 |
Eigler, NL; Forrester, JS; Hutsell, TC; Kaul, S; Litvack, FI; Makkar, RR; Nakamura, M; Shah, PK | 1 |
Clambey, ET; Katusić, ZS; Lee, HC | 1 |
Bina, S; Jing, M; Ledvina, MA; Muldoon, SM; Panico, FG; Panico, JL | 1 |
Andrioli, G; Bellavite, P; Benoni, G; Degan, M; Gaino, S; Lechi, A; Lechi, C; Minuz, P; Ortolani, R; Tommasoli, R; Zuliani, V | 1 |
Gulati, A; Sen, AP; Sharma, AC; Singh, G | 1 |
Sang, JC; Schachter, D | 1 |
Chen, L; Mehta, JL; Salafranca, MN | 1 |
Bernasconi, S; Dejana, E; Del Maschio, A; Martín-Padura, I | 1 |
Bellver, T; Casado, S; Esteban, A; Farré, J; García-Durán, M; Guerra, JI; López-Farré, A; Mata, P; Montón, M; Rico, LA; Romero, J; Sánchez de Miguel, L; Sierra, MP | 1 |
Cecchi, E; Failli, P; Giotti, A; Laffi, G; Mugelli, A; Tosti-Guerra, C; Zilletti, L | 1 |
Frölich, JC; Ikic, M; Raida, M; Tewes, KS; Tsikas, D | 1 |
Antonelli, E; Del Soldato, P; Federici, B; Fiorucci, S; Mannucci, R; Miglietti, M; Morelli, A; Morelli, O; Santucci, L | 1 |
Nakaki, T | 1 |
Blanco, E; De La Cruz, JP; Sánchez de la Cuesta, F | 1 |
Grosser, N; Schröder, H | 2 |
Bernareggi, M; Berti, F; Colonna, VD; Manfredi, B; Rossoni, G | 1 |
Degan, M; Gaino, S; Lechi, A; Meneguzzi, A; Minuz, P; Santonastaso, CL; Soldato, PD; Zuliani, V | 1 |
Monobe, H; Nakamura, K; Ohe, T; Yamanari, H | 1 |
Hong, E; Huang, F; Sun, J; Xiu, Q | 1 |
Arriero, MM; Casado, S; Celdran, A; de la Pinta, JC; Escribano, M; García-Mendez, A; Jimenez, P; López-Farré, A; Manzarbeitia, F; Muñoz-Alameda, L; Reyero, A | 1 |
Fiorucci, S; Ignarro, LJ; Wallace, JL | 1 |
Berti, F; Del Soldato, P; Manfredi, B; Rossoni, G | 1 |
Angelini, GD; Ascione, R; Capoun, R; Jeremy, JY; Shukla, N; Talpahewa, S | 1 |
Berti, F; Del Soldato, P; Manfredi, B; Polvani, G; Rossoni, G | 1 |
Chen, J; Gao, J; Hundley, TR; Kashfi, K; Kopelovich, L; Nath, N; Rigas, B; Williams, JL | 1 |
Donati, S; Filippi, S; Forti, G; Lotti, F; Maggi, M; Mancina, R; Marini, M; Mondaini, N; Montorsi, F; Morelli, A; Salonia, A; Vannelli, GB; Vignozzi, L | 1 |
Breese, E; Del Soldato, P; Mitchell, J; Warner, T; Wood, E; Zacharowski, P | 1 |
Cockcroft, JR; Coffey, MJ; Coles, B; Lewis, MJ; Morrow, JD; O'Donnell, VB; Sanchez, S; Williams, PC | 1 |
Bode-Böger, SM; Martens-Lobenhoffer, J; Scalera, F; Schröder, H; Täger, M | 1 |
Abraham, R; Biaggioni, I; Diedrich, A; Farley, G; Gamboa, A; Paranjape, SY; Shibao, C | 1 |
Bhattacharya, G; Girish, GV; Sinha, AK | 1 |
Clough, GF; Gooding, KM; Hannemann, MM; Shore, AC; Tooke, JE | 1 |
Andersson, J; Bengtsson, T; Grenegård, M; Kälvegren, H | 1 |
Bhattacharya, G; Bhattacharya, R; Bhattacharyya, M; Karmohapatra, SK; Sinha, AK | 1 |
Ferro, A; Jackson, G; Ji, Y; Liu, Z; O'Kane, P; Queen, L; Xie, L | 1 |
Handa, M; Ikeda, Y; Okamura, Y; Watanabe, N; Yoshida, H | 1 |
Bhatia, S; Medhi, B; Parmar, VS; Prasad, AK; Priya, N; Raj, HG; Singh, P | 1 |
Anfossi, G; Barale, C; Cavalot, F; Doronzo, G; Mattiello, L; Pagliarino, A; Russo, I; Trovati, M; Viretto, M | 1 |
Capogrossi, M; Gaetani, E; Gatto, I; Giarretta, I; Hlatky, L; Landolfi, R; Marcantoni, M; Neri, V; Palladino, M; Pola, R; Silver, M; Smith, RC; Stigliano, E; Straino, S | 1 |
Hamzah, AS; Kek, TL; Mansor, NS; Mohammat, MF; Salleh, MZ; Sani, MH; Shaameri, Z; Zakaria, ZA | 1 |
Gambaryan, S; Geiger, J; Kharazova, A; Panteleev, M; Rukoyatkina, N; Shpakova, V | 1 |
Huang, MZ; Jiao, ZH; Kong, XJ; Li, JY; Li, SH; Liu, XW; Ma, N; Qin, Z; Shen, DS; Yang, YJ | 1 |
7 review(s) available for aspirin and cyclic gmp
Article | Year |
---|---|
[Lysosomes, cyclic nucleotides and retinal degeneration].
Topics: Animals; Aspirin; Cortisone; Cyclic AMP; Cyclic GMP; Darkness; DNA; Lysosomes; Mice; Nucleotides, Cyclic; Rats; Rats, Inbred Strains; Retina; Retinal Degeneration; Salicylates; Species Specificity | 1978 |
[Present status and prospects of platelet inhibitors].
Topics: Adenosine; Aspirin; Blood Platelets; Cyclic AMP; Cyclic GMP; Depression, Chemical; Drug Combinations; Drug Synergism; Humans; Phosphodiesterase Inhibitors; Platelet Aggregation; Prostaglandins E; Serotonin; Theophylline; Thrombosis | 1976 |
Proposed metabolic dysfunctions in diabetic microthromboses and microangiopathy.
Topics: Alprostadil; Aspirin; Blood Platelets; Calcimycin; Collagen; Cyclic AMP; Cyclic GMP; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dinoprost; Dinoprostone; Humans; Indomethacin; Models, Biological; Platelet Aggregation; Prostaglandins; Prostaglandins E; Prostaglandins F; Thromboxane A2 | 1979 |
The pathophysiology of asthma. Extrinsic influences other than immunologic.
Topics: Aerosols; Air Pollution; Aspirin; Asthma; Asthma, Exercise-Induced; Autonomic Nervous System; Cyclic AMP; Cyclic GMP; Emotions; Humans; Humidity; Immunoglobulin E; Occupational Diseases; Parasympathetic Nervous System; Receptors, Adrenergic; Respiratory Tract Infections; Tobacco Smoke Pollution | 1984 |
Cyclic nucleotides in hemostasis and thrombosis.
Topics: Aspirin; Blood Platelets; Calcium; Cyclic AMP; Cyclic GMP; Diet; Hemostasis; Humans; Male; Phosphorylation; Platelet Aggregation; Prostaglandins; Protein Kinases; Proteins; Thrombosis; Thromboxanes | 1980 |
[Nitic oxide and natriuretic peptides].
Topics: Adenylyl Cyclase Inhibitors; Aspirin; Cyclic GMP; Drug Design; Humans; Natriuretic Agents; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfhydryl Compounds; Sulfones | 2000 |
Potential cardioprotective actions of no-releasing aspirin.
Topics: Animals; Apoptosis; Arteriosclerosis; Aspirin; Caspase Inhibitors; Cell Adhesion; Cyclic GMP; Cytokines; Heart; Humans; Hypertension; Myocardial Infarction; Stroke | 2002 |
4 trial(s) available for aspirin and cyclic gmp
Article | Year |
---|---|
Effects of inhaled nitric oxide compared with aspirin on platelet function in vivo in healthy subjects.
Topics: Administration, Inhalation; Administration, Oral; Aspirin; Bleeding Time; Blood Platelets; Cyclic GMP; Dose-Response Relationship, Drug; Humans; Nitric Oxide; Platelet Aggregation | 1996 |
In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets.
Topics: Aspirin; Blood Platelets; Cyclic GMP; Dose-Response Relationship, Drug; Health; Humans; Isoenzymes; Nitric Oxide; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Thromboxanes; Time Factors | 2005 |
Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole.
Topics: Acetylcholine; Adenosine; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Flow Velocity; Cardiovascular System; Cross-Over Studies; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Models, Biological; Nitric Oxide; Nitroprusside; Phosphoric Diester Hydrolases; Time Factors; Vasodilator Agents | 2005 |
Maximum skin hyperaemia induced by local heating: possible mechanisms.
Topics: Aspirin; Cetirizine; Cross-Over Studies; Cyclic GMP; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists, Non-Sedating; Hot Temperature; Humans; Hyperemia; Laser-Doppler Flowmetry; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Piperazines; Prostaglandins; Purines; Reference Values; Regional Blood Flow; Sildenafil Citrate; Skin; Sulfones; Ultrasonography | 2006 |
76 other study(ies) available for aspirin and cyclic gmp
Article | Year |
---|---|
Human lung tissue and anaphylaxis. I. The role of cyclic GMP as a modulator of the immunologically induced secretory process.
Topics: Acetylcholine; Anaphylaxis; Antigens; Aspirin; Atropine; Carbachol; Cyclic AMP; Cyclic GMP; Histamine Release; Humans; In Vitro Techniques; Kinetics; Lung; Prostaglandins F; SRS-A | 1977 |
The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation.
Topics: Anaphylaxis; Arachidonic Acids; Aspirin; Cyclic AMP; Cyclic GMP; Histamine H1 Antagonists; Histamine H2 Antagonists; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Lung; Prostaglandins F; SRS-A | 1978 |
Inhibition by non-steroidal anti-inflammatory agents of the ascorbate-induced elevations of platelet cyclic AMP levels.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; 5,8,11,14-Eicosatetraynoic Acid; Anaerobiosis; Ascorbic Acid; Aspirin; Blood Platelets; Cyclic GMP; Enzyme Activation; Humans; Oxygen Consumption; Phospholipases A; Phospholipases A2 | 1979 |
Prostaglandins as intracellular messengers.
Topics: Adenylyl Cyclases; Animals; Arachidonic Acids; Aspirin; Blood Pressure; Calcium; Chemical Phenomena; Chemistry; Cyclic AMP; Cyclic GMP; Fatty Acids, Unsaturated; Feedback; Female; Hormones; Humans; Male; Models, Chemical; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Prostaglandins A; Prostaglandins E; Prostaglandins F; Structure-Activity Relationship | 1975 |
Roles of cyclic nucleotides in platelet function.
Topics: Acetylcholine; Adenosine Diphosphate; Adenylyl Cyclases; Arginine Vasopressin; Aspirin; Blood Platelets; Calcium; Carbachol; Collagen; Cyclic AMP; Cyclic GMP; Epinephrine; Humans; In Vitro Techniques; Indomethacin; Papaverine; Platelet Aggregation; Prostaglandins E | 1975 |
Effect of aspirin on normal and cholera toxin-stimulated intestinal electrolyte transport.
Topics: Animals; Aspirin; Biological Transport; Cholera; Cyclic AMP; Cyclic GMP; Electrolytes; Electrophysiology; Epinephrine; Ileum; Intestinal Absorption; Intestinal Mucosa; Ions; Male; Norepinephrine; Phenoxybenzamine; Phentolamine; Rabbits; Stimulation, Chemical; Toxins, Biological | 1976 |
Possible relation of prostaglandins to PMN-derived mediators of host metabolic responses to inflammation.
Topics: Amino Acids; Animals; Aspirin; Biological Assay; Bucladesine; Cells, Cultured; Cyclic GMP; Cyclooxygenase Inhibitors; Indomethacin; Inflammation; Leukocyte Count; Mixed Function Oxygenases; Morphine; Neutrophils; Prostaglandins; Prostaglandins E; Prostaglandins F; Rabbits; Zinc | 1977 |
The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
Topics: Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Humans; Indomethacin; Peroxides; Platelet Aggregation; Prostaglandins | 1977 |
Effects of blood glucose levels on aspirin-induced gastric mucosal damage.
Topics: Adrenal Cortex Hormones; Animals; Aspirin; Blood Glucose; Bucladesine; Cyclic AMP; Cyclic GMP; Diabetes Mellitus, Experimental; Dibutyryl Cyclic GMP; Fasting; Female; Gastric Mucosa; Glucosamine; Glycoproteins; Hypoglycemia; Insulin; Rats; Stomach Ulcer | 1977 |
Elevation of the cyclic GMP concentration in human platelets by sodium ascorbate and 5-hydroxytryptamine.
Topics: Ascorbic Acid; Aspirin; Blood Platelets; Collagen; Cyclic GMP; Dose-Response Relationship, Drug; Epinephrine; Humans; Serotonin; Thrombin | 1977 |
The predominant contribution of platelets to baseline and ascorbate-stimulated increments in cyclic GMP in human mononuclear leukocyte preparations.
Topics: Ascorbic Acid; Aspirin; Blood Platelets; Carrier Proteins; Cyclic GMP; Humans; Indomethacin; Monocytes; Radioimmunoassay | 1978 |
Sensitivity to cyclic nucleotides and to aspirin of the kininogen-consuming system activated by adrenaline or carbamylcholine in rat blood.
Topics: Animals; Aspirin; Carbachol; Cyclic AMP; Cyclic GMP; Epinephrine; Kininogens; Kinins; Male; Muscle Contraction; Rats | 1978 |
Divergent effects of prostaglandin synthesis inhibitors on pulmonary cyclic 3', 5'-adenosine monophosphate and cyclic 3', 5'-guanosine monophosphate levels in untreated and histamine sensitized mice.
Topics: Animals; Aspirin; Cyclic AMP; Cyclic GMP; Female; Histamine; Indomethacin; Lung; Mice; Mice, Inbred ICR; Pertussis Vaccine; Prostaglandins | 1979 |
The effect of low dose of 12-O-tetradecanoyl-phorbol-13-acetate on collagen platelet interactions.
Topics: Aspirin; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Microscopy, Electron; Phosphorylation; Platelet Aggregation; Serotonin; Tetradecanoylphorbol Acetate | 1989 |
The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Aspirin; Blood Platelets; Collagen; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Humans; In Vitro Techniques; Nitric Oxide; Phthalazines; Platelet Adhesiveness; Purinones; Superoxide Dismutase; Thrombin | 1987 |
Low-density lipoproteins increase intracellular calcium in aequorin-loaded platelets.
Topics: Aequorin; Aspirin; Blood Platelets; Calcium; Cyclic GMP; Humans; Isoquinolines; Lipoproteins, LDL; Luminescence; Luminescent Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrahydroisoquinolines | 1988 |
Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha.
Topics: Adenosine Diphosphate; Aspirin; Cyclic AMP; Cyclic GMP; Dinoprost; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins F; Prostaglandins H; Prostaglandins, Synthetic; Thrombin | 1985 |
Studies on the effect of different inhibitors of arachidonic acid metabolism on glyceryltrinitrate-induced relaxation and cGMP elevation in bovine vascular tissue.
Topics: Animals; Arachidonic Acids; Aspirin; Blood Vessels; Cattle; Cyclic GMP; In Vitro Techniques; Masoprocol; Muscle Contraction; Muscle Relaxation; Neuromuscular Depolarizing Agents; Nitroglycerin; Phenylephrine; Quinacrine; Tranylcypromine | 1987 |
Effects of bradykinin and indomethacin on cyclic GMP and cyclic AMP in lung slices.
Topics: Acetylcholine; Angiotensin II; Animals; Aspirin; Bradykinin; Culture Techniques; Cyclic AMP; Cyclic GMP; Guinea Pigs; Histamine; Indomethacin; Isoproterenol; Lung; Peptides; Promethazine; Stimulation, Chemical; Theophylline | 1973 |
Effects of collagen and of aspirin on the concentration of guanosine 3':5'-cyclic monophosphate in human blood platelets: measurement by a prelabelling technique.
Topics: Aspirin; Blood Platelets; Chromatography, Thin Layer; Collagen; Cyclic GMP; Guanine; Humans; In Vitro Techniques; Platelet Adhesiveness; Time Factors; Tritium | 1974 |
Studies on the role of cyclic GMP in the control of human platelet function.
Topics: 1-Methyl-3-isobutylxanthine; Arachidonic Acids; Aspirin; Blood Platelets; Cyclic GMP; Humans; Indomethacin | 1980 |
Independent mechanisms for bradykinin-mediated prostaglandin E2 and cyclic GMP syntheses in rabbit renal inner medulla slices.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Bradykinin; Calcium; Cyclic GMP; Dinoprostone; In Vitro Techniques; Kidney Medulla; Prostaglandins E; Rabbits; Time Factors | 1982 |
Interferon enhancement of natural killer cell cytotoxicity: role of cyclic nucleotides.
Topics: Animals; Aspirin; Calcium; Cyclic AMP; Cyclic GMP; Cytotoxicity, Immunologic; Humans; Indomethacin; Interferons; Killer Cells, Natural; Lymphocytes; Mice; Mice, Inbred BALB C; Time Factors | 1982 |
Treatment of canine spontaneous diabetes mellitus with aspirin.
Topics: Animals; Aspirin; Cyclic AMP; Cyclic GMP; Diabetes Mellitus; Diabetic Retinopathy; Disease Models, Animal; Dog Diseases; Dogs; Drug Therapy, Combination; Epoprostenol; Platelet Count | 1980 |
Effects of 12-O-tetradecanoyl phorbol 13-acetate on platelet aggregation.
Topics: Aspirin; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Humans; Phorbols; Phosphorylation; Platelet Aggregation; Serotonin; Tetradecanoylphorbol Acetate | 1981 |
The effects of arachidonic acid, PGI2, and 6-keto-PGF1 alpha on cyclic nucleotide concentrations in a ventilated and artificially perfused isolated dog lung.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cyclic AMP; Cyclic GMP; Dogs; Epoprostenol; In Vitro Techniques; Indomethacin; Kinetics; Lung; Perfusion; Prostaglandins; Tranylcypromine | 1982 |
Simultaneous manipulation of the nitric oxide and prostanoid pathways reduces myocardial reperfusion injury.
Topics: Animals; Arginine; Aspirin; Cardioplegic Solutions; Coronary Circulation; Cyclic GMP; Glucose; Heart; Heart Rate; Hydroxyl Radical; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandins; Rats; Rats, Sprague-Dawley; Tromethamine; Vascular Resistance | 1995 |
Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats.
Topics: Animals; Arginine; Arteries; Aspirin; Cardiovascular System; Cyclic GMP; Gases; Hemodynamics; Hemoglobins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sodium Chloride; Vascular Resistance | 1995 |
Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries.
Topics: Animals; Aspirin; Blood Platelets; Blood Pressure; Coronary Circulation; Coronary Thrombosis; Cyclic GMP; Disease Models, Animal; Dogs; Epinephrine; Heart Rate; Injections, Intravenous; Nitroprusside | 1993 |
Role of cyclic nucleotides in rapid platelet adhesion to collagen.
Topics: Adenylyl Cyclases; Alprostadil; Antigens, CD; Apyrase; Aspirin; Blood Platelets; Collagen; Creatine Kinase; Cyclic AMP; Cyclic GMP; Guanylate Cyclase; Humans; Integrin beta1; Integrins; Nitroprusside; Platelet Adhesiveness | 1994 |
Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin.
Topics: 6-Ketoprostaglandin F1 alpha; Adenylyl Cyclases; Animals; Animals, Newborn; Aspirin; Brain; Cells, Cultured; Cyclic AMP; Cyclic GMP; Dinoprostone; Endothelium, Vascular; Enzyme Activation; Iloprost; In Vitro Techniques; Indomethacin; Microcirculation; Muscle, Smooth, Vascular; Receptors, Epoprostenol; Receptors, Prostaglandin; Signal Transduction; Swine | 1995 |
What effect does controlling platelets have on atherosclerosis?
Topics: Adenylyl Cyclases; Animals; Arteriosclerosis; Aspirin; Blood Platelets; Calcium; Capillary Permeability; Cattle; Collagen; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Myocardial Ischemia; Nitric Oxide; Plasminogen Activator Inhibitor 1; Platelet Activation; Platelet Aggregation; Tissue Plasminogen Activator | 1995 |
Contractile effects of diaspirin cross-linked hemoglobin (DCLHb) on isolated porcine blood vessels.
Topics: Acetylcholine; Analysis of Variance; Animals; Arginine; Arteries; Aspirin; Cyclic GMP; Endothelium, Vascular; Hemoglobins; In Vitro Techniques; Kinetics; Methemoglobin; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Organ Specificity; Potassium Chloride; Pulmonary Veins; Swine; Veins | 1995 |
Potentiation of endogenous nitric oxide with superoxide dismutase inhibits platelet-mediated thrombosis in injured and stenotic arteries.
Topics: Animals; Arteries; Aspirin; Blood Platelets; Cardiovascular Agents; Constriction, Pathologic; Cyclic GMP; Drug Evaluation, Preclinical; Drug Synergism; Nitric Oxide; Nitroglycerin; Organometallic Compounds; Rabbits; Random Allocation; Superoxide Dismutase; Thrombosis; Time Factors | 1995 |
Cholera toxin-induced small intestinal secretion has a secretory effect on the colon of the rat.
Topics: Animals; Aspirin; Biological Transport; Cholera Toxin; Colon; Cyclic GMP; Denervation; Electrolytes; Intestines; Jejunum; Male; Nervous System Physiological Phenomena; Osmolar Concentration; Rats; Rats, Wistar; Water | 1995 |
Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1.
Topics: Animals; Aspirin; Blood Platelets; Calcium; Citrulline; Cyclic GMP; Endothelins; Humans; In Vitro Techniques; Neutrophils; Nitric Oxide; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Rabbits | 1995 |
Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Topics: Adenosine Triphosphate; Aspirin; Blood Platelets; Cyclic AMP; Cyclic GMP; Drug Interactions; Humans; Iloprost; In Vitro Techniques; Iodine Radioisotopes; Molsidomine; Nitric Oxide; Nitroprusside; Phosphorylation; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors | 1995 |
Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation.
Topics: Animals; Aspirin; Biological Transport; Blood Platelets; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cattle; Cell Membrane Permeability; Cyclic AMP; Cyclic GMP; Epoprostenol; Humans; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Ionomycin; Kinetics; Nitroprusside; Phosphorylation; Receptors, Cytoplasmic and Nuclear; Serum Albumin, Bovine; Thrombin; Time Factors | 1996 |
Inhibition of acute stent thrombosis under high-shear flow conditions by a nitric oxide donor, DMHD/NO. An ex vivo porcine arteriovenous shunt study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Bleeding Time; Blood Coagulation; Blood Platelets; Cyclic GMP; Hemodynamics; Heparin; Hexanones; Nitric Oxide; Platelet Aggregation; Stents; Swine; Thrombosis; Whole Blood Coagulation Time | 1996 |
Crosslinked hemoglobin inhibits endothelium-dependent relaxations in isolated canine arteries.
Topics: Acetylcholine; Animals; Aspirin; Blood Substitutes; Calcimycin; Cyclic AMP; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Femoral Artery; Hemoglobins; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renal Artery; Vasodilation | 1996 |
Diaspirin cross-linked hemoglobin does not alter isolated human umbilical artery or vein tone.
Topics: Acetylcholine; Animals; Aspirin; Cyclic GMP; Dose-Response Relationship, Drug; Hemoglobins; Humans; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; Serotonin; Substance P; Swine; Umbilical Arteries; Umbilical Veins; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production.
Topics: Adult; Aspirin; Blood Platelets; Calcium; Cyclic GMP; Humans; P-Selectin; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboxane A2 | 1996 |
Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat.
Topics: Animals; Aspirin; Blood Substitutes; Cyclic GMP; Endothelin-1; Endothelins; Enzyme Inhibitors; Gases; Hemodynamics; Hemoglobins; Hemorrhage; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxygen; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Resuscitation; Survival Analysis | 1997 |
Regional differentiation in the rat aorta: effects of cyclooxygenase inhibitors.
Topics: 1-Methyl-3-isobutylxanthine; Analysis of Variance; Animals; Aorta, Abdominal; Aorta, Thoracic; Aspirin; Cyclic GMP; Cyclooxygenase Inhibitors; Endothelium, Vascular; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Prostaglandin H2; Prostaglandins H; Rats; Rats, Sprague-Dawley | 1997 |
Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets.
Topics: Aspirin; Blood Platelets; Blotting, Western; Calcium; Cyclic GMP; Cyclooxygenase Inhibitors; Cytosol; Humans; Indomethacin; Nitric Oxide Synthase; Osmolar Concentration; Thromboxane B2 | 1997 |
Triggering of beta 1-integrin chain induces platelet adhesion to cultured endothelium.
Topics: Alprostadil; Animals; Antibodies, Monoclonal; Aspirin; Azepines; Blood Platelets; Cells, Cultured; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Extracellular Matrix Proteins; Humans; Integrin beta1; Mice; Mice, Inbred BALB C; Nitroprusside; P-Selectin; Platelet Adhesiveness; Platelet Membrane Glycoproteins; Protein Kinase C; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serotonin; Staurosporine; Thienopyridines; Triazoles | 1997 |
Comparison of in vitro effects of triflusal and acetysalicylic acid on nitric oxide synthesis by human neutrophils.
Topics: Aspirin; Cyclic GMP; Cyclooxygenase Inhibitors; Humans; Neutrophils; Nitric Oxide; Platelet Aggregation Inhibitors; Salicylates | 1998 |
Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets.
Topics: Acetophenones; Aspirin; Blood Platelets; Cyclic GMP; Cyclooxygenase Inhibitors; Diclofenac; Humans; Indomethacin; Indoprofen; Nitric Oxide; Nitroprusside; Penicillamine; Phospholipases A; Thromboxane B2 | 1998 |
Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets.
Topics: Arachidonic Acid; Aspirin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Cyclic GMP; Cysteine; Fatty Acids, Unsaturated; Glutathione; Guanylate Cyclase; Humans; Hydrazines; Inhibitory Concentration 50; Nitric Oxide; Nitrites; Nitroprusside; Nitroso Compounds; Oxadiazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinoxalines; S-Nitrosoglutathione; S-Nitrosothiols; Thromboxane A2 | 1999 |
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase Inhibitors; Caspases; Cyclic GMP; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Gastric Mucosa; Humans; In Situ Nick-End Labeling; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Rats; Salicylates; Time Factors; Tumor Necrosis Factor-alpha; U937 Cells | 1999 |
Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway.
Topics: Adult; Aspirin; Blood Platelets; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Humans; Male; Neutrophils; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors | 2000 |
A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate.
Topics: Animals; Aspirin; Cell Line; Cyclic GMP; Cyclic N-Oxides; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Epithelial Cells; Free Radical Scavengers; Imidazoles; Kidney; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Protein Binding; Swine | 2000 |
The nitroderivative of aspirin, NCX 4016, reduces infarct size caused by myocardial ischemia-reperfusion in the anesthetized rat.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Creatine Kinase; Cyclic GMP; Fibrinolytic Agents; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; NG-Nitroarginine Methyl Ester; Peroxidase; Platelet Aggregation Inhibitors; Rats; Rats, Wistar | 2001 |
NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes.
Topics: Aspirin; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrinolytic Agents; Guanylate Cyclase; Humans; Interleukin-6; Lipopolysaccharides; Monocytes; Nitric Oxide; Oxadiazoles; Quinoxalines; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha | 2001 |
Effects of low-dose aspirin on endothelial function in hypertensive patients.
Topics: Aged; Aspirin; Blood Volume; Case-Control Studies; Cyclic GMP; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Regional Blood Flow; Vasodilation; Vasodilator Agents | 2001 |
Anti-platelet and anti-thrombotic effects of triacetylshikimic acid in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Abdominal; Aspirin; Blood Platelets; Cyclic AMP; Cyclic GMP; Male; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Prothrombin Time; Radioimmunoassay; Rats; Rats, Wistar; Shikimic Acid; Thrombin Time; Thrombosis; Thromboxane B2 | 2002 |
Aspirin protected the nitric oxide/cyclic GMP generating system in human peritoneum.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Down-Regulation; Escherichia coli; Guanylate Cyclase; Humans; Immunohistochemistry; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peritoneum; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase | 2001 |
NCX 4016, a nitric oxide-releasing aspirin, modulates adrenergic vasoconstriction in the perfused rat tail artery.
Topics: Animals; Arteries; Aspirin; Cyclic GMP; Dose-Response Relationship, Drug; Electric Stimulation; Male; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Perfusion; Rats; Rats, Wistar; Tail; Vasoconstriction | 2002 |
Nitric oxide donating aspirins: novel drugs for the treatment of saphenous vein graft failure.
Topics: Aged; Aspirin; Cell Division; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Middle Aged; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroprusside; Platelet Aggregation Inhibitors; Saphenous Vein; Vasodilation | 2003 |
Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway.
Topics: Animals; Aspirin; Cattle; Cell Survival; Cells, Cultured; Citrulline; Cyclic GMP; Cyclic N-Oxides; Cytoprotection; Diclofenac; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Hydrogen Peroxide; Imidazoles; Indomethacin; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Swine | 2003 |
Nitric oxide-releasing aspirin inhibits vasoconstriction in perfused tail artery of normotensive and spontaneously hypertensive rats.
Topics: Animals; Arteries; Aspirin; Blood Pressure; Cyclic GMP; Dose-Response Relationship, Drug; In Vitro Techniques; Nitrates; Nitric Oxide Donors; Nitrites; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tail; Thromboxane B2; Time Factors; Vasoconstriction | 2003 |
Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemopreventi
Topics: Aspirin; beta Catenin; Cell Nucleus; Colonic Neoplasms; Cyclic GMP; Cyclooxygenase 2; Cytoskeletal Proteins; DNA, Neoplasm; HT29 Cells; Humans; Isoenzymes; Membrane Proteins; NF-kappa B; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Signal Transduction; Trans-Activators; Transcription Factors | 2003 |
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Androgens; Animals; Aspirin; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Gene Expression Regulation, Enzymologic; Humans; Male; Middle Aged; Myocytes, Smooth Muscle; Nitric Oxide; Nitro Compounds; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rabbits; RNA, Messenger; Vas Deferens | 2005 |
NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Flurbiprofen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indomethacin; Membrane Proteins; Naproxen; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Prostaglandin-Endoperoxide Synthases; Purinones; Synovial Membrane; Time Factors | 2005 |
Aspirin reduces endothelial cell senescence.
Topics: Aspirin; Cells, Cultured; Cellular Senescence; Cyclic GMP; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species | 2005 |
The role of insulin dependent NO synthesis in the impaired production of maspin in human breast cancer.
Topics: Aged; Alprostadil; Aspirin; Binding, Competitive; Breast Neoplasms; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Genes, Tumor Suppressor; Humans; Insulin; Middle Aged; Neutrophils; Nitric Oxide; Receptor, Insulin; Sensitivity and Specificity; Serpins; Time Factors; Up-Regulation | 2006 |
Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors.
Topics: Adenosine Triphosphate; Adult; Aspirin; Caffeic Acids; Cell Line, Tumor; Chlamydophila pneumoniae; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Flavanones; Humans; Lipoxygenase Inhibitors; Piroxicam; Platelet Activating Factor; Platelet Aggregation; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12 | 2007 |
The role of leucocytes in the acetyl salicylic acid (aspirin) induced nitric oxide synthesis in the production of interferon-alpha, a potent inhibitor of platelet aggregation and a thrombolytic agent.
Topics: Adenosine Diphosphate; Adult; Animals; Aspirin; Blood Platelets; Cyclic AMP; Cyclic GMP; Female; Fibrin; Fibrinolysis; Humans; Interferon-alpha; Leukocytes; Male; Mice; Middle Aged; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Rich Plasma; Thrombosis | 2009 |
Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity.
Topics: Acetylation; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; HeLa Cells; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Serine; Transfection; Young Adult | 2009 |
Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation.
Topics: Aspirin; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, Gs; Hemostasis; Humans; Ligands; Platelet Aggregation; Quinolines; Ristocetin; Shear Strength; Tirofiban; Tyrosine; Urea; von Willebrand Factor | 2011 |
Characterization of a unique dihydropyrimidinone, ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model.
Topics: Adenosine Diphosphate; Animals; Aorta; Aspirin; Blood Platelets; Collagen; Cyclic GMP; Drug Synergism; Inflammation Mediators; Inhibitory Concentration 50; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Platelet Aggregation Inhibitors; Pyrimidinones; Rats; Rats, Sprague-Dawley; Thrombin; Thromboplastin; Thrombosis | 2011 |
High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets.
Topics: Adult; Amifostine; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cell Adhesion Molecules; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Drug Resistance; Female; Humans; Hyperglycemia; Lysine; Male; Microfilament Proteins; Nitric Oxide; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Protein Processing, Post-Translational; Second Messenger Systems; Thromboxanes; Vasodilator Agents; Young Adult | 2012 |
Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
Topics: Animals; Apoptosis; Aspirin; Carcinoma, Lewis Lung; Caveolin 1; Cell Movement; Cell Proliferation; Cells, Cultured; Cellular Senescence; Coculture Techniques; Corneal Neovascularization; Cyclic GMP; Disease Models, Animal; Dystrophin; Endothelial Cells; Endothelium, Vascular; Ischemia; Mice; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Mutation; Myoblasts, Skeletal; Neovascularization, Pathologic; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Time Factors | 2013 |
Antinociceptive activity of a synthetic oxopyrrolidine-based compound, ASH21374, and determination of its possible mechanisms.
Topics: Analgesics; Analgesics, Opioid; Animals; Aspirin; Capsaicin; Cyclic GMP; Glutamic Acid; Male; Mice; Mice, Inbred BALB C; Morphine; Motor Activity; Naloxone; Naltrexone; Nitric Oxide; Pyrrolidines; Rats, Sprague-Dawley; Receptors, Opioid | 2013 |
Multifaceted effects of arachidonic acid and interaction with cyclic nucleotides in human platelets.
Topics: Arachidonic Acid; Aspirin; Blood Platelets; Cell Survival; Cyclic AMP; Cyclic GMP; Drug Resistance; Humans; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Protein Kinases | 2018 |
Aspirin eugenol ester inhibits agonist-induced platelet aggregation in vitro by regulating PI3K/Akt, MAPK and Sirt 1/CD40L pathways.
Topics: Animals; Aspirin; Calcium; Caspase 3; CD40 Ligand; Cell Adhesion Molecules; Cyclic AMP; Cyclic GMP; Eugenol; Gene Expression Regulation; Intracellular Space; L-Lactate Dehydrogenase; Male; MAP Kinase Signaling System; Microfilament Proteins; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Platelet Aggregation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Sirtuin 1; Thromboxane A2 | 2019 |